LANDONI, Luca
 Distribuzione geografica
Continente #
EU - Europa 2.687
NA - Nord America 2.472
AS - Asia 1.452
SA - Sud America 29
AF - Africa 22
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.673
Nazione #
US - Stati Uniti d'America 2.445
CN - Cina 882
IT - Italia 663
GB - Regno Unito 580
SG - Singapore 412
SE - Svezia 301
IE - Irlanda 264
RU - Federazione Russa 226
FR - Francia 224
DE - Germania 201
FI - Finlandia 99
UA - Ucraina 33
HK - Hong Kong 31
JP - Giappone 29
CA - Canada 25
VN - Vietnam 20
BE - Belgio 19
KR - Corea 18
NL - Olanda 17
CZ - Repubblica Ceca 16
TG - Togo 15
BR - Brasile 13
IN - India 9
TR - Turchia 9
AU - Australia 7
CH - Svizzera 7
CL - Cile 7
ID - Indonesia 7
IR - Iran 6
RO - Romania 6
DK - Danimarca 5
AZ - Azerbaigian 4
EG - Egitto 4
LT - Lituania 4
LV - Lettonia 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
IL - Israele 3
PH - Filippine 3
PK - Pakistan 3
PL - Polonia 3
AR - Argentina 2
BO - Bolivia 2
EC - Ecuador 2
EU - Europa 2
GR - Grecia 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AM - Armenia 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
BW - Botswana 1
CO - Colombia 1
ES - Italia 1
HN - Honduras 1
HU - Ungheria 1
IQ - Iraq 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SI - Slovenia 1
TW - Taiwan 1
Totale 6.673
Città #
Chandler 646
Southend 548
Singapore 344
Dublin 254
Ashburn 203
Beijing 161
Jacksonville 150
Verona 125
Ann Arbor 102
Woodbridge 101
New York 99
Lawrence 75
Princeton 75
Helsinki 74
Jinan 66
Wilmington 64
Shenyang 55
Nanjing 48
Redmond 48
Houston 43
Sindelfingen 40
Milan 36
Bologna 33
Hebei 33
Tianjin 31
Haikou 30
Hong Kong 30
Rome 28
Seattle 26
Washington 26
Taiyuan 25
Santa Clara 24
Hangzhou 23
Ningbo 23
Zhengzhou 21
Nanchang 20
Tokyo 20
Brussels 19
Dallas 19
Los Angeles 19
Changsha 18
Guangzhou 18
Seoul 18
Redwood City 16
Lomé 15
Boardman 14
Brno 14
Taizhou 14
Fairfield 13
Toronto 12
Falls Church 10
Jiaxing 10
Kent 10
Vito 10
Amsterdam 9
Dong Ket 8
Dongguan 8
Fuzhou 8
Genova 8
Menlo Park 8
Munich 8
Norwalk 8
Ottawa 8
Chions 7
Florence 7
Foersloev 7
Lanzhou 7
London 7
Rimini 7
Foresto 6
Jakarta 6
Lancaster 6
Moscow 6
Pignone 6
Shanghai 6
Chicago 5
Hamburg 5
Osaka 5
Padova 5
Treviso 5
Cairo 4
Dearborn 4
Falkenstein 4
Grezzana 4
Lappeenranta 4
Santiago 4
Sondrio 4
Vadstena 4
Acerra 3
Baku 3
Bergamo 3
Borgo Valsugana 3
Clearwater 3
Darmstadt 3
Des Moines 3
Detroit 3
Ferentino 3
Genazzano 3
Jönköping 3
Landshut 3
Totale 4.243
Nome #
ULCERE DIFFICILI DEGLI ARTI INFERIORI: UN CASO DI ERITEMA INDURATO DI BAZIN 330
Whole-genome landscape of pancreatic neuroendocrine tumours 174
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 123
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 122
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 120
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 120
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 117
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 113
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 112
ANOMALIE ASSOCIATE DELL'APPENDICE VERMIFORME. DESCRIZIONE E DISCUSSIONE DI UN CASO 109
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 108
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 107
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 107
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 106
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 105
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 104
CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms 103
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 102
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 100
TREATMENT OF SIX HEPATIC ARTERY ANEURYSMS 94
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment 94
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 93
Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification 92
Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and 18F-FDG Uptake 92
Digital Subtraction of Magnetic Resonance Images Improves Detection and Characterization of Pancreatic Neuroendocrine Neoplasms 88
Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium 88
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 88
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 88
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 87
Synchronous superior mesenteric-portal vein resection during pancreatectomy for T3 head adenocarcinoma: Perioperative outcomes and prognostic implications of histologically confirmed venous infiltration 84
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 83
Laser Treatment of Pancreatic Cancer with Immunostimulating Interstitial Laser Thermotherapy Protocol: Safety and Feasibility Results From Two Phase 2a Studies 83
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19) 83
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 81
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 78
Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts 77
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 77
Histogram analysis of ADC maps: assessment of intra-tumoral heterogeneity and correlation with the biological behavior of pancreatic neuroendocrine neoplasms 76
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 75
Imaging presentation of pancreatic neuroendocrine neoplasms 74
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 74
Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers 73
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 73
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 72
3D-CT texture analysis of neuroendocrine pancreatic neoplasms 71
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 71
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 69
Long term outcome after minimally invasive and open Warshaw and Kimura techniques for spleen-preserving distal pancreatectomy: International multicenter retrospective study 69
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 69
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors 68
Hemodynamics and remodeling of the portal confluence in patients with malignancies of the pancreatic head: a pilot study towards planned and circumferential vein resections 68
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 67
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 66
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial 64
Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome 64
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 64
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 63
Robotic Dual-Console Distal Pancreatectomy: Could it be Considered a Safe Approach and Surgical Teaching even in Pancreatic Surgery? A Retrospective Observational Study Cohort 61
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 60
Endoscopic Ultrasound Features Associated with Malignancy and Aggressiveness of Nonhypovascular Solid Pancreatic Lesions: Results from a Prospective Observational Study 59
Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors 59
Pancreatic surgery is a safe teaching model for tutoring residents in the setting of a high-volume academic hospital: a retrospective analysis of surgical and pathological outcomes 57
Differentiation of pancreatic neuroendocrine tumor grade comparing 3D CT texture analysis and relative CT enhancement ratios 56
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 55
Negative pressure wound therapy for prevention of surgical site infection in patients at high risk after clean-contaminated major pancreatic resections: A single-center, phase 3, randomized clinical trial 54
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms 54
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 54
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 53
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 53
Assessment of difficulty in laparoscopic distal pancreatectomy: a modification of the Japanese difficulty scoring system - A single-center high-volume experience 52
Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study 51
Pancreatic surgery during COVID-19 pandemic: major activity disruption of a third-level referral center during 2020 50
401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience 49
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring 48
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size 42
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 38
Long-term organoid culture of a small intestinal neuroendocrine tumor 37
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 35
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 35
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 34
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 34
Transcriptome analysis of primary sporadic neuroendocrine tumours of the intestine identified three different molecular subgroups 33
Impact of Bacillus Calmette-Guérin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection 32
Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study 32
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 29
Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors 29
Thirty-day prevalence and clinical impact of fluid collections at the resection margin after distal pancreatectomy: Follow-up of a multicentric randomized controlled trial 29
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 26
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 26
Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center 23
Outcomes of patients undergoing elective liver and pancreas cancer surgery during the SARS-CoV-2 pandemic: an international, multicentre, prospective cohort study 22
Author response to: Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 19
Mortality and pulmonary complications in emergency general surgery patients with COVID-19: A large international multicenter study 17
Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma 16
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres) 11
Totale 6.846
Categoria #
all - tutte 29.149
article - articoli 27.682
book - libri 0
conference - conferenze 1.467
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020327 0 0 0 0 0 0 56 32 34 41 54 110
2020/2021741 104 79 57 138 74 75 21 23 44 25 55 46
2021/2022724 55 202 30 74 30 16 12 35 44 14 58 154
2022/20231.757 92 240 139 323 108 443 39 108 183 16 39 27
2023/20241.143 32 76 121 120 106 221 88 57 21 50 196 55
2024/20251.031 124 128 141 388 135 113 2 0 0 0 0 0
Totale 6.846